Abstract-Owing to their success in clinical practice, the prevalence of cardiovascular implants is continuously increasing.
C linical cardiovascular medicine is increasingly relying on implantable devices, such as surgically placed valvular prostheses, transcatheter aortic valve implantations (TAVI), pacemakers, implantable cardiac defibrillators, or left ventricular assist devices (LVADs). [1] [2] [3] [4] Devices yield proven survival benefits. Accordingly, the fraction of patients with cardiovascular implants is steadily increasing. Those patients, however, are exposed to additional risks of infection, including the risks of early infection associated with the procedure and those associated with the presence of artificial material inside the body, which facilitates the adherence of bacteria. This may lead to the formation of biofilm, which efficiently protects bacteria from elimination. 5 Consequentially, there is a continuously elevated risk of infection even at late stages after device implantation. 6, 7 Device-related infection may be life threatening, and therapeutic decision making is often complicated, with options ranging from specific drug therapy to device extraction and replacement. [8] [9] [10] This emphasizes the need for accurate diagnostic techniques, which aid in the decision process by early identification, localization, and severity assessment of device-related infection. Unfortunately, the presence of an implant also complicates imaging tests because it may create artefacts and thereby limit accuracy. Hence, imaging of device-related infection often requires a multimodality approach, and morphological imaging is more and more amended by specific molecular-targeted imaging techniques. 11 This review will focus on noninvasive imaging of prosthetic valve endocarditis as the most frequent clinical situation, whereas other clinical scenarios, such as pacemaker and LVAD infection, will also be explored. Although all available imaging modalities will be covered, the upcoming trend of an increasing use of molecular imaging techniques will be specifically emphasized.
Imaging in Suspected Prosthetic Valve Endocarditis-What Do the Guidelines Say?
The clinical condition associated with infection of a valvular prosthesis is infective endocarditis (IE). IE may also result from endocardial components of a cardiac implanted electronic device or an LVAD. The current state-of-the-art in management of IE has been summarized in recent guidelines of several societies, including the 2015 American Heart Association scientific statement, 12 the 2015 European Society of Cardiology (ESC) guidelines, 9 and the 2017 American Association for Thoracic Surgery expert consensus guidelines. 13 All 3 documents agree in the role of transthoracic echocardiography (TTE) as a primary diagnostic tool in all cases of suspected IE, including those with implants. TTE should, however, be supplemented by transesophageal echocardiography (TEE) in prosthetic valve IE, owing to its higher sensitivity. The guidelines differ significantly, however, in the amount of detail dedicated to the use of advanced tomographic imaging techniques and their relative value in native versus prosthetic valve IE: The American Heart Association scientific statement does not devote much detail on the specific challenges of prosthetic valve IE and only briefly summarizes potential applications of imaging modalities other than echocardiography, without clear recommendations for their clinical use. 12 It concludes that multimodality imaging in IE is likely to increase with increasing clinical evidence of its usefulness.
The most recent guidelines of the American Association for Thoracic Surgery focus on the surgeon's needs but nevertheless provide some more detail on nonechocardiographic imaging. 13 The value of ECG-gated computed tomography (CT) is highlighted, which provides accuracy similar to TEE in the preoperative evaluation of prosthetic valve IE and gives potentially valuable additional morphological information. Also, radionuclide imaging techniques are mentioned, and their role for reduction of misdiagnosed IE by increasing sensitivity without loss of specificity on one hand and for detection of peripheral emboli and remote infectious foci by whole-body imaging on the other hand, is highlighted. It is nevertheless noted that no larger multicenter trials are available to support these promising complementary imaging techniques.
The most detail is provided by the ESC guidelines. 9 First, this document proposes reference centers with specialized endocarditis teams. It is specifically mentioned that such centers should have access to all diagnostic procedures and that imaging specialists should be present on the endocarditis team when available. Next, in a diagnostic section, after in-depth discussion of the key role of TTE and TEE, the additional value of advanced imaging is described. This includes CT, which may aid in accurate detection of abscesses/pseudoaneurysms and prosthesis dehiscence along with extracardiac alterations. It also includes magnetic resonance imaging (MRI), which is primarily used to identify cerebral consequences of IE with high sensitivity, and it describes nuclear imaging techniques, which include single photon emission CT (SPECT) with autologous In-111-or Tc-99m-labeled leukocytes or positron emission tomography (PET) with the glucose analogue F-18 fluorodeoxyglucose (FDG). Both techniques aim at detecting leukocyte infiltration at the sites of infection, and the localization is improved by an additional CT component in SPECT/CT or PET/CT hybrid equipment. The added value of nuclear imaging is seen in a more accurate classification of unclear cases according to modified Duke criteria and in detection of peripheral inflammatory and embolic foci owing to the whole-body technique. Finally, the ESC guidelines also give a stepwise diagnostic algorithm, which distinguishes between native and prosthetic valves in cases with possible (neither confirmed nor rejected) IE according to Duke criteria. In prosthetic valves, the use of nuclear imaging and cardiac CT in addition to repeat TTE/TEE is proposed, to derive ESC modified diagnostic criteria, which include results of all imaging tests in addition to blood culture and clinical findings to define the final likelihood of IE and thus subsequent therapy. Despite an increasing recognition, the guidelines also point toward an existing gap between capabilities of nuclear imaging and clinical trial evidence supporting incremental impact on management and outcomes, which should be bridged by future efforts.
Infection of Cardiac Devices Other Than Prosthetic Valves
Like prosthetic valve IE, the infection of other cardiac implants is generally a severe condition with high associated mortality, which requires an early accurate diagnosis that often is challenging. Similar to surgically placed valvular prostheses, interventionally placed (TAVI) systems are prone to infection. 14 Given the recent growth in TAVI procedures, this complication is likely to become more prevalent, and specific challenges of diagnosis and management in TAVI IE will need to be defined in more detail.
Also, cardiac implantable electronic devices, such as pacemakers or implantable cardiac defibrillators, may be infected at the time of implantation, 15 as a consequence of skin erosion or by hematogenous bacterial seeding. Here, it is important to distinguish between local infection of the device pocket or an extension of infection to electrode leads and surrounding endocardial structures, which is then defined as devicerelated IE. 9 TTE and TEE are key diagnostic techniques, but false negatives may be encountered and Duke criteria have a low sensitivity in this specific setting. 15, 16 Nuclear imaging may again be useful in difficult cases, to distinguish pocket infection from IE and to identify extracardiac foci. 17 Robust confirmation of IE is important because definitive diagnosis will lead to device extraction. 18 Another specific setting of implantable devices prone to infection are LVADs, which are multicomponent devices where an internal pump is connected with an external power source via a driveline. This creates a potential entrance pathway for bacteria. LVAD infection may present as driveline infection, pump pocket infection, and LVAD-associated IE. 10 Accurate detection of localization and severity is important because it may guide surgical intervention (driveline revision, pump pocket draining, vacuum therapy, or even device replacement). 19, 20 In addition to ultrasound, CT is useful for identification of fluid collections and abscesses. 10, 21 Here, the potential of nuclear imaging using SPECT/CT or PET/ CT for detection and localization of infection is also increasingly supported. 22, 23 The serial use for monitoring of therapy is another potential application, which, however, requires more scientific evidence.
Current Status of Morphology-Driven Imaging Modalities Echocardiography
Echocardiography is the first-line imaging technique for diagnosis of cardiac device-related infections and IE. 9, 12 Generally, 2-dimensional echocardiography is readily available without the need of cost-intensive large equipment and infrastructure. Because of technical improvement, echo machine size has been steadily decreased, whereas advanced imaging options, such as 3-dimensional (3D) echocardiography, have been added. Diagnosis of prosthetic valve IE, like native valve IE, is initially based on the modified Duke criteria. 24 Representing a major criterion of the modified Duke criteria, echocardiographic findings are a cornerstone for IE diagnosis. Sensitivity for the diagnosis of vegetations by TTE or TEE is 70% and 95% for native valves but goes down to 50% and 90% for prosthetic valves, respectively. 9,24,27 Specificity is around 90% for both TTE and TEE. Of note, negative TTE/TEE cannot completely rule out the presence of IE and has to be repeated after 5 to 7 days if clinical suspicion remains high. 9 Additional value of a third examination is low. 28 For initial evaluation of suspected IE, TTE is the first imaging test owing to its noninvasive nature. But even if TTE images are of high quality, TEE must be performed in the majority of patients because of improved image quality, higher sensitivity, and in particular, for the evaluation of perivalvular disease extension, for example, abscess and fistula 29 ( Figure 1 ). A recent meta-analysis suggested that even modern TTE has the potential to miss a large fraction of vegetations detected by TEE. 30 Hence, only if TTE with high imaging quality is negative and the clinical likelihood of IE is low can imaging by TTE be considered sufficient. 9, 27 Diagnosis of IE is difficult in prosthetic valves because of impaired imaging quality caused by artifacts or acoustic shadows. 9, 24, 27 Falsepositive results are caused by difficulties in the differentiation between vegetations and structures such as thrombi, prolaps, myxomatous changes, tumors, Lambi excrements, noninfectious vegetations, and valvular strands. 31 Also, the diagnosis of IE is particularly challenging if intracardiac devices are involved. Lead aggregations, which can be found in ≤20% of pacemaker patients without infection, cannot be differentiated from vegetations by imaging criteria only, even with TEE. 32 More recently, 3D echocardiography has been introduced as a potential improvement for IE assessment. Real-time 3D-TEE refines the assessment of cardiac morphology and structure in any possible plane by rapid online acquisition of 3D volumes. This is helpful in the assessment of perivalvular extension of infection, valve perforation, and dehiscence of prosthetic valves.
33 3D-TEE seems to determine vegetation size more exactly than 2-dimensional-TEE, leading to a better prediction of the embolic risk. 34 However, its major limitation is the reduced spatial resolution because of a reduced frame rate, 35 which may impair the detection of small vegetations. Accordingly, 3D-TEE should be regarded as supplementary to standard 2-dimensional echocardiography. 9, 36 In addition, intracardiac echocardiography represents an emerging imaging modality, which is mostly used for guidance and monitoring of interventional procedures in electrophysiology and valvular or congenital heart disease, for example, TAVI, Mitraclip procedures, left atrial appendage closure, closure of interatrial communications, or paravalvular leaks. 37 Intracardiac echocardiography may also help in patients with high clinical suspicion of implantable electronic device-related endocarditis but negative TEE. 38 Owing to free intracardiac positioning of the probe, intracardiac echocardiography overcomes limitations of TEE caused by the large distance between probe and right ventricle (far-field limitation). Placing the probe in the right ventricle outflow tract allows for excellent structural imaging of aortic and mitral valve. Because intracardiac echocardiography is invasive, it may serve as a third option in suspected prosthetic valve or implantable devicerelated IE if TTE and TEE are inconclusive. Finally, heart failure, perivalvular extension of the disease, and embolic events represent the most relevant complications of IE and determine short-and long-term prognosis, as well as indication and timing of surgery (emergency, urgent, elective). 9 In the presence of heart failure, echocardiography identifies underlying causes and hemodynamic parameters, such as valve destruction with severe regurgitation, pulmonary hypertension, and ventricular dysfunction and dilatation. Additionally, echocardiography identifies risk factors for embolic events, such as highly mobile vegetations, vegetation size (>10 mm), vegetations located at the mitral valve (particular anterior leaflet; Figure 2 ), and increase of vegetation size. 39 This further consolidates the role of echocardiography beyond plain diagnosis, for risk assessment, prognosis evaluation, and indication and timing of surgery.
Radiograph CT
Contrast-enhanced, ECG-gated CT provides high-resolution images of heart, vessels, and valve region but also of the surrounding extracardiac anatomy. It robustly identifies complications like perivalvular abscesses, real-or pseudoaneurysms, dissections, fistulas, or even perforations (Figure 3) . Accuracy is at least equal to that of echocardiography and probably better than TEE in the setting of prosthetic valve IE. 40, 41 Using fast, large field-of-view, or even dual-source CT scanners of newest generation, motion-free, low-dose, and high-resolution images have emerged as a standard. CT can be extended to obtain information about the whole-body extent of infection 36, 42, 43 and it may detect noninfectious relevant findings. 44 In critical patients, where MRI is not feasible, fast cerebral imaging may aid to determine neurological complications. In pulmonary/right-sided endocarditis, CT may reveal concomitant pulmonary disease, including abscesses and infarcts. 9, 12 And finally, images of the coronary arteries and calcium scoring may be performed as an alternative to invasive angiography, for the rule out of concomitant coronary artery disease and for planning of surgery.
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Magnetic Resonance Imaging
Guidelines focus on the use of MRI for brain imaging in IE, where it is the most sensitive tool to identify cerebral complications. 9, 13 Brain lesions (mostly ischemic) are identified in ≤25% of subjects with nondefinite IE and no neurological symptoms, leading to earlier, more accurate diagnosis. 45 In subjects with neurological symptoms, abnormalities are seen in the majority of cases, 46 but characterization of brain lesions with regards to size, location, and etiology also adds to planning of therapy, especially to the timing of surgery.
It should be noted that cardiac MRI may also be used in the diagnosis of IE. 47 Here, contrast-enhancing lesions may identify subendocardial perimyocardial involvement. 47, 48 Cine images may identify floating dynamic masses or vegetation in a manner similar to echocardiography. 49, 50 Complications like abscesses, aneurysms, dissections, or fistulas are identified, and, using multiple sequences, the composition of masses may be characterized comprehensibly to distinguish thrombus, infectious vegetation, or even a tumor. 51 But evidence on the usefulness of cardiac MRI in IE is limited, and in case of metal implants, MRI may be unsafe and contraindicated. Even if safety is not a concern, such as in prosthetic heart valves or some electronic devices, the assessment of regions around the implant (which are those prone to infection) will be compromised by artefacts.
Advent (and Revival) of Molecular-Targeted and Cellular Imaging
Inflammation-targeted nuclear imaging techniques have been introduced decades ago and are well established in various inflammatory/infectious diseases. 52 Their acceptance in IE has been initially limited owing to low resolution, difficult localization, and limited short-term availability, but the field has advanced, and 3 major factors have contributed to a recent revival and emergence of nuclear imaging techniques for the detection of IE and cardiovascular implant infection:
First, as mentioned above, the prevalence of patients with valvular prostheses and other cardiac implanted devices is increasing. The recent success of TAVI will further contribute. 53 Echocardiography, as also described above, has limitations in this setting, leading to a higher demand for additional imaging tools. 9, 13 Second, recent trends in nuclear imaging technology, along with their success in clinical oncology, have resulted in a broad availability of hybrid imaging devices, such as SPECT/CT 54 and PET/CT. 55 Those devices enable a more accurate localization of the radiotracer signal by combining tomographic emission data with morphology from a radiograph CT. Because the target region in cardiac devicerelated infections is small and close to blood pool (which may contribute to elevated background signal from circulating radiotracer), colocalization of the nuclear imaging signal with a concomitantly acquired CT has benefitted its clinical application by facilitating image interpretation and increasing clinical acceptance.
And third, the detailed implementation of nuclear imaging in the recent ESC guidelines for IE 9 along with the establishment of reference centers and endocarditis teams has greatly Figure 4 . Simultaneous dual-isotope studies in 3 patients with suspected endocarditis, using a solid-state detector equipped dedicated cardiac single photon emission computed tomography (SPECT) camera, In-111-labeled white blood cells (WBCs) to identify inflammation (green color scale) and a Tc-99 m myocardial perfusion tracer to localize the valve plane (red color scale). A, Normal study (only blood pool activity in WBC images). B, Periprosthetic WBC focus in proximity of an artificial aortic valve, consistent with endocarditis (arrows; confirmed as abscess at surgery). C, WBC focus in region of mitral valve implant, consistent with endocarditis (arrows). Reprinted from Caobelli et al 65 with permission. Copyright ©, the European Society of Cardiology. HLA indicates horizontal long axis; SA, short axis; and VLA, vertical long axis. Imaging of Implant Infection increased the awareness of clinicians toward the usefulness of nuclear imaging techniques. 56 
Radiolabeled White Blood Cell SPECT/CT
SPECT/CT imaging relies on the use of autologous leukocytes, which are isolated and radiolabelled ex vivo using either the longer-lived, more stable In-111 oxine 57 or the shorter-lived, more readily available Tc-99 m hexamethylpropyleneamine oxime. 58 After readministration, the labeled white blood cells (WBCs) accumulate in a time-dependent fashion in inflammatory lesions. For detection of IE, early images (routinely obtained after 4 hours) are frequently hampered by residual blood pool activity from circulating WBCs. Accordingly, late images at 24 hours, sometimes even 48 hours, are required for diagnosis. Tc-99 m-labeled antigranulocyte antibodies, which bind to inflammatory cells in vivo, are a potential alternative to WBCs for SPECT/CT imaging, 59 but their availability has been regionally limited after initial introduction in the 1990s, and recent literature about their usefulness is limited.
WBC SPECT/CT has been shown to have value for a more accurate subsequent classification in cases with initially possible IE according to modified Duke criteria. 60 Of note, scintigraphic techniques generally combine a dedicated SPECT/ CT scan of the cardiothoracic region with planar whole-body images, enabling the detection of extracardiac inflammatory foci as a cause or consequence of IE. 61 This does not only refine diagnosis but also affects subsequent therapeutic decision making. 9 In multicomponent devices, such as pacemakers or LVADs, the localization of an infection is also facilitated and may be relevant for conservative treatment or surgery. 62 Direct comparison of WBC SPECT/CT with FDG PET/ CT has shown that it is more specific but less sensitive. 63 This is readily explained by the nature of the leukocyte-derived imaging signal, which is more specific for inflammation than the elevated glucose metabolism detected by FDG PET/CT. And it is explained by the lower count statistics and resolution of SPECT/CT versus PET/CT, which results in lower sensitivity. Accordingly, several reference centers, where all imaging techniques are available, prefer to use the more sensitive PET/CT technique as a first-line nuclear imaging test, whereas WBC SPECT/CT is performed as a second step in selected positive PET/CT cases to add specificity if needed. 64 This strategy also accounts for other limitations of WBC SPECT/ CT, which lie in the long duration of preparation and imaging procedure, as well as the labor intensity because of handling of blood and need for serial time-point imaging.
Most recently, efforts have been made to overcome the somewhat limited sensitivity of WBC SPECT/CT, by introducing simultaneous dual-isotope imaging using highsensitivity solid-state detector-equipped cardiac SPECT cameras. 65 The detector material in these cameras, which are increasingly used for low-dose myocardial perfusion SPECT, is cadmium-zinc-telluride. In addition to the significantly elevated detection sensitivity of those cameras, which is a result of their small, cardiac-focused design, the cadmiumzinc-telluride detectors also have superior energy resolution, which facilitates the detection of multiple isotopes in the field of view. 66 This allows for a coinjection of a Tc-99 m-labeled myocardial perfusion tracer to localize the valve plane, which is simultaneously imaged along with In-111-labeled WBCs. The approach makes use of the higher count sensitivity of the cadmium-zinc-telluride device, and it provides a clearcut definition of the valve plane for localization of eventual inflammatory hot spots (Figure 4 ). It also overcomes limitations of SPECT/CT coregistration, which may be impaired because of misalignment between the SPECT acquisition (an average over the respiratory cycle) and the CT acquisition (representing only 1 phase of the cycle). 67, 68 Any available CT can also be realigned accurately to the nuclear data based on the myocardial perfusion information-an option that is not feasible for WBC images because of lack of landmarks. Taken together, the strengths of this new technique lead to an improvement of image quality, reader confidence, and diagnostic accuracy (both sensitivity and specificity) over standard SPECT/CT and planar scintigraphy. Accordingly, if cadmiumzinc-telluride SPECT technology is available, this novel dualisotope approach may be beneficial in the workup of IE.
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F-18 FDG PET/CT
PET/CT makes use of the elevated glucose metabolism in activated leukocytes, which is traced by the glucose analogue, F-18 FDG. 70 It is generally performed using a single acquisition time point, at around 1 hour after tracer administration. Later imaging has not been shown to have additional value and may even contribute to false-positive results. 71 Preparation of the patient is another issue which requires attention. Along with the method used for image interpretation, it may strongly influence diagnostic value. 72 Low-carbohydrate diet, fasting, and heparin administration has been recommended to minimize FDG uptake in myocardium as a potential confounding factor, 72 but final evidence on what is the most useful protocol is still lacking. Also, because any proliferating or activated cell type may show increased FDG uptake, guidelines do not recommend FDG PET/CT within the first 3 months after surgical placement of a prosthesis/implant, during which endogenous repair mechanisms and tissue healing may cause false-positive results. 9 It should be noted, however, that the effect of time after surgery is still somewhat uncertain because some other studies did not note a significant impact on diagnostic accuracy. 73 The natural course of FDG uptake during the healing process after surgery should be a subject of more detailed analysis. A recent study described homogeneous FDG uptake in noninfected prosthetic valves, which remained stable over time, raising specific caution and relevance of the uptake pattern. 74 Further, several other pathological conditions can mimic the pattern of focally increased 18F-FDG uptake that is typically observed in IE, such as active thrombi, soft atherosclerotic plaques, vasculitis, primary cardiac tumors, cardiac metastasis from a noncardiac tumor, and foreign body reactions. Finally, it should be noted that dense implant material may cause artificial elevation of FDG uptake in attenuationcorrected images because of overcorrection and misalignment between CT and emission scan. This can be accounted for by including noncorrected images along with the attenuationcorrected images into the interpretation. Any hot spot on corrected images should also be visible versus background in its immediate vicinity on noncorrected images. 75 
Imaging of Implant Infection
Nevertheless, FDG PET/CT has been shown to have excellent sensitivity for detecting prosthetic valve IE 9 ( Figure 5 ). Its specificity is more of a concern, for the various reasons mentioned above. Hence, care must be taken not to over-read FDG PET/CT scans 76 or to seek additional confirmation, that is, by the more specific WBC scan, in questionably positive cases ( Figure 6 ). Commonly, the valvular and periprosthetic regions are analyzed visually, and semiquantitative uptake parameters (standardized uptake values) can be used to assist in diagnosis. It has been suggested that a standardized uptake and In-111-labeled white blood cell (WBC) single photon emission computed tomography (SPECT)/CT in a patient with suspected endocarditis because of recurrent fever, enterococcal bacteremia, 1 year after implantation of an aortic valve prosthesis and a biventricular pacemaker. Serial echocardiography remained equivocal. A, FDG shows mild uptake in the aortic valve region (SUVpeak 2.5, arrows), which is not typical for endocarditis but does not allow for definitive rule out. B, WBC SPECT/CT, obtained subsequently, shows no uptake in valve region, effectively ruling out endocarditis. MIP indicates maximum intensity projection; and SUV, standardized uptake value. Imaging of Implant Infection value max of >3.7 or a standardized uptake value ratio (prosthesis material/bloodpool background) of >1.69 has the best diagnostic accuracy as a threshold above which diagnosis is established. 73 Also, modern PET/CT devices are equipped with fast multislice CT components which enable contrastenhanced cardiac imaging. This allows for the combination of PET with CT angiography-a unique feature, which has been shown to be beneficial because it leads to the detection of more abscesses/collections and to identification of other lesions relevant for therapeutic decision making, such as pseudoaneurysms, fistula, thrombi, or coronary artery involvement. In this regard, the combination of PET/CT angiography is superior to PET with noncontrast CT or echocardiography. 73 Finally, PET/CT is a whole-body technique, which will give additional information about infectious and noninfectious lesions outside of the cardiac region. 77, 78 Such lesions may have a significant impact on further patient handling ( Figure 7) .
Lastly, the use of FDG PET/CT is increasingly expanded for diagnosing infections of other cardiac devices. A recent systematic review of FDG PET/CT and WBC scan literature in cardiac implanted electronic devices showed the strongest amount of supportive data for FDG PET/CT, with a pooled sensitivity and specificity of 87% and 94%. 17 Utilization is also increasingly expanded toward LVAD systems, 22, 79 where not only early diagnosis but also localization of infection (driveline versus pump pocket versus outflow tract) may be critical for therapeutic management (Figure 8 ).
Limitations of Currently Practiced Molecular Imaging Approaches
Despite their increasing clinical penetration, the nuclear imaging techniques still share some common weaknesses. The first is the loss of time that is often induced by a referral to nuclear imaging. It is clearly necessary to diagnose IE or other infectious heart diseases at an early stage to avoid complications and enable rapid and adequate therapy. Whereas echocardiography is readily available and can be completed bedside, and whereas CT is often available in emergency rooms or on-call settings, nuclear imaging requires ordering and delivery of radiotracers, WBC scans include laborious preparation, and PET/CT scanners are frequently overbooked with prescheduled oncological scans, hindering immediate availability. Completion of the tests also takes longer than for echocardiography or CT, in case of the WBC, even days. This limits the early use of otherwise powerful testsa problem that can only be overcome at specialized centers by opening specific camera slots for fast referral and diagnosis.
Also, antibiotic therapy has often been started at the time of nuclear imaging. This may reduce the sensitivity of both WBC SPECT/CT and FDG PET/CT for diagnosing IE. This, however, also suggests that monitoring of the effectiveness of therapy may be a potential application for biological imaging techniques, which is still largely unexploited. 80 The field of nuclear imaging clearly needs prospective studies and further efforts to fully exploit its potential in the management of IE. The Table compares In summary, the field of imaging for cardiovascular implant infection is rapidly expanding and transforming. It is obvious that a single-modality approach based on echocardiography does not suffice anymore to meet the challenges posed by complex devices. Accordingly, echocardiography is supported by advanced tomographic imaging techniques, which all have their strengths and weaknesses. A multimodality approach is needed, and imaging experts require knowledge in all available techniques. Integrated assays, such as the recently proposed combination of PET and CT angiography by use of PET/CT hybrid devices, 73, 76 are desirable and will see increasing clinical application. 64 Such an approach combines the strengths of morphological and molecular imaging techniques and thereby helps to overcome the weaknesses of individual techniques when A, Strong FDG uptake surrounding pump pocket, confirmed on both attenuation corrected (AC) and noncorrected (NC) images (arrows). Note FDG uptake in viable myocardium (vM) and defects in scar areas (Sc), highlighting the ischemic origin of heart failure. B, Strong FDG uptake along driveline, from skin entry toward pump, confirming pathway of infection. MIP indicates maximum intensity projection; and SUV, standardized uptake value. Although it poses challenges for scheduling and interdisciplinary team interaction, early (and broad) application of nonechocardiographic multimodal techniques in the initial workup of suspected implant-associated IE is desirable. This will most likely have a beneficial effect on diagnostic value, and it will enable accurate follow-up to monitor success of therapeutic measures. Importantly, the proposed algorithms for early implementation of, for example, PET/CT angiography for IE diagnosis and for monitoring of therapy will require prospective validation to corroborate their clinical usefulness and overcome reimbursement challenges in a field where only small-scale studies are available to date.
Toward More Specific Molecular Targets
Another area of improvement is the type of radiopharmaceutical used for IE workup. Current clinical agents have significant limitations, lying in the nonspecific nature of FDG (which is taken up in many types of tissues) and in the complexity of preparation and limited accuracy of radiolabeled WBCs. One way to overcome those limitations may be the development of WBC labeling techniques with longer-lived positron emitting agents, enabling more accurate and specific PET/ CT imaging. 69 Another approach could be the implementation of more specific leukocyte-targeted in vivo imaging agents, which at the same time have no or little confounding myocardial uptake, such as the amino acid C-11 methionine 81, 82 or the CXCR4 chemokine receptor ligand Ga-68 pentixafor. 83 The ultimate challenge is to develop specific imaging agents, which accumulate in the infectious agents, such as bacteria or fungi directly, without accumulation in host tissue. Several bacteria-specific imaging agents, which make use of metabolic pathways only used by bacteria, such as uptake of maltodextrins or sorbitol, have been explored experimentally, including F-18 maltohexaose, 84 F-18-deoxysorbitol, 85 or more recently, F-18 maltotriose. 86 Further agents may follow. 87 Although none of the bacteria-specific agents has been applied in the clinics to date, IE is likely to be a primary application in the future. It should be noted that the broadening spectrum of molecular imaging agents may even enable the dissection of different components of infection in early diagnosis and in response to therapy (Figure 9 ). Presence and amount of bacteria may be identified using bacteria-targeted agents. The immune response to the infectious agent may then be identified using leukocyte-targeted imaging. This may even be supplemented by tracers of healing processes, such as angiogenesis, 88 to determine the likelihood of repair after therapy and to distinguish between infection-related or healing-related origin of leukocyte presence. And finally, integrity of the surrounding tissue may be interrogated by viability imaging, and morphological imaging will aid in localization of molecular signals and in identifying structural alterations. Although such an approach of combined multitracer imaging is still a vision, it should serve as a stimulus for further development in this rapidly developing area of device infection imaging.
Conclusion
Implant-associated infection is an increasingly relevant clinical challenge in cardiovascular medicine. Diagnosis Figure 9 . Schematic display of cellular targets, and estimated uptake intensity of various established and experimental imaging agents for detection of implant infection. Red color reflects intensity of uptake in respective cell type. Red text identifies currently nonapproved experimental tracers. FDG indicates F-18 fluorodeoxyglucose. Imaging of Implant Infection frequently requires a multimodality approach to overcome limitations of individual techniques. This leads to an increasing implementation of biology-targeted molecular and cellular nuclear imaging techniques, such as FDG PET/CT and WBC SPECT/CT, which should be available to every endocarditis team as part of their diagnostic armamentarium. Further developments in integrated multimodality imaging technology and in radiopharmaceutical sciences, along with increasing clinical evidence for usefulness in early diagnosis and in subsequent therapy monitoring, will contribute to an expected future growth of the field.
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